• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 1988-2006 年黑色素瘤厚度趋势。

Melanoma thickness trends in the United States, 1988-2006.

机构信息

Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island 02908-4799, USA.

出版信息

J Invest Dermatol. 2010 Mar;130(3):793-7. doi: 10.1038/jid.2009.328. Epub 2009 Oct 15.

DOI:10.1038/jid.2009.328
PMID:19829301
Abstract

Over the past two decades, numerous efforts have been initiated to improve screening and early detection of melanoma both in the United States and worldwide. It is commonly believed that these efforts have contributed to the stabilization of melanoma mortality, and that the proportion of thick melanoma with unfavorable prognosis is on the decline. Data obtained from 17 population-based cancer registries of the Surveillance Epidemiology and End Result (SEER) program of the National Cancer Institute for 1988-2006 were used to examine trends in melanoma tumor thickness. For malignant melanoma cases with recorded thickness, the proportionate distribution among four thickness categories (<or=1, 1.01-2, 2.01-4, and >4 mm) remained relatively stable over the 19-year study period, however, for melanomas resulting in death, the proportion of thick tumors increased. The most substantial change occurred in the proportion of melanoma in situ, which nearly doubled from 1988 to 2006. Surveillance and early detection efforts in the United States have not resulted in a substantial reduction in the proportion of tumors with prognostically unfavorable thickness. Continued improvement and new methods of screening, especially among demographics with higher incidence of thick tumors, is necessary.

摘要

在过去的二十年中,美国和世界范围内都开展了许多旨在改善黑色素瘤筛查和早期检测的工作。人们普遍认为,这些努力有助于稳定黑色素瘤的死亡率,且预后不良的厚型黑色素瘤的比例正在下降。本研究使用了美国国家癌症研究所的监测、流行病学和最终结果(SEER)项目的 17 个基于人群的癌症登记处的数据,来检测黑色素瘤肿瘤厚度的变化趋势。对于有记录厚度的恶性黑色素瘤病例,在 19 年的研究期间,四个厚度类别(<或=1、1.01-2、2.01-4 和>4mm)之间的比例分布相对稳定,然而,对于导致死亡的黑色素瘤,厚型肿瘤的比例增加。变化最显著的是原位黑色素瘤的比例,从 1988 年到 2006 年几乎翻了一番。美国的监测和早期检测工作并没有导致预后不良的厚型肿瘤比例的大幅下降。需要继续改进和开发新的筛查方法,特别是针对厚型肿瘤发病率较高的人群。

相似文献

1
Melanoma thickness trends in the United States, 1988-2006.美国 1988-2006 年黑色素瘤厚度趋势。
J Invest Dermatol. 2010 Mar;130(3):793-7. doi: 10.1038/jid.2009.328. Epub 2009 Oct 15.
2
Early detection of thick melanomas in the United States: beware of the nodular subtype.美国厚黑色素瘤的早期检测:谨防结节亚型。
Arch Dermatol. 2005 Jun;141(6):745-50. doi: 10.1001/archderm.141.6.745.
3
Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.总体及厚度亚分类的薄黑素瘤的死亡率负担和预后:SEER 登记数据,1992-2013 年。
J Am Acad Dermatol. 2017 Feb;76(2):258-263. doi: 10.1016/j.jaad.2016.10.018. Epub 2016 Nov 22.
4
The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.美国监测、流行病学和最终结果计划中,1989-2008 年未知厚度黑素瘤病例的特征及其潜在影响。
Cancer Epidemiol. 2013 Feb;37(1):64-70. doi: 10.1016/j.canep.2012.08.010. Epub 2012 Sep 18.
5
National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.全国范围内侵袭性黑色素瘤和原位黑色素瘤行Mohs 显微外科手术的利用模式。
J Am Acad Dermatol. 2015 Jun;72(6):1060-5. doi: 10.1016/j.jaad.2015.02.1122. Epub 2015 Mar 29.
6
The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.1978年至2007年美国结节状亚型对黑色素瘤死亡率的影响。
Arch Dermatol. 2012 Jan;148(1):30-6. doi: 10.1001/archdermatol.2011.264. Epub 2011 Sep 19.
7
Melanoma surveillance in the United States: overview of methods.美国黑色素瘤监测:方法概述。
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S6-16. doi: 10.1016/j.jaad.2011.04.037.
8
Comparative mortality of patients diagnosed with localized and in situ melanomas.
J Insur Med. 1998;30(3):157-68.
9
Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.1989年至2009年美国黑色素瘤厚度与生存趋势
J Natl Cancer Inst. 2015 Nov 12;108(1). doi: 10.1093/jnci/djv294. Print 2016 Jan.
10
Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?癌症登记处能否表明在人群层面上,治疗是否有助于提高皮肤黑色素瘤的生存率?
J Eval Clin Pract. 2014 Feb;20(1):74-80. doi: 10.1111/jep.12081. Epub 2013 Sep 23.

引用本文的文献

1
Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.早期黑色素瘤进展至晚期黑色素瘤的模式:对生存随访的影响。
Melanoma Manag. 2024 Dec;11(1):2424708. doi: 10.1080/20450885.2024.2424708. Epub 2024 Dec 2.
2
Phosphatase and Tensin Homolog (PTEN) Expression as a Surrogate Biomarker Correlated With the Depth of Invasion in Cutaneous Malignant Melanoma.磷酸酶与张力蛋白同源物(PTEN)表达作为与皮肤恶性黑色素瘤浸润深度相关的替代生物标志物
Cureus. 2023 Sep 15;15(9):e45295. doi: 10.7759/cureus.45295. eCollection 2023 Sep.
3
Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2-T3 Disease.
针对美国癌症联合委员会(AJCC)第8版T2-T3期疾病患者存档组织中早期皮肤黑色素瘤的免疫组织化学7生物标志物预后检测(免疫印记)的分析验证
Diagnostics (Basel). 2023 Sep 29;13(19):3096. doi: 10.3390/diagnostics13193096.
4
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.早期原发性皮肤黑色素瘤中的突变全景:InterMEL 研究。
Pigment Cell Melanoma Res. 2022 Nov;35(6):605-612. doi: 10.1111/pcmr.13058. Epub 2022 Aug 12.
5
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.皮肤黑色素瘤管理中预后基因表达谱检测应用的专家共识:皮肤癌预防工作组共识
Dermatol Ther (Heidelb). 2022 Apr;12(4):807-823. doi: 10.1007/s13555-022-00709-x. Epub 2022 Mar 30.
6
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas.弥漫性PRAME表达在区分薄型黑色素瘤与重度发育异常痣方面具有高度特异性,但无法区分转移性与非转移性薄型黑色素瘤。
Cancers (Basel). 2021 Jul 31;13(15):3864. doi: 10.3390/cancers13153864.
7
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature.使用七标记免疫组化特征识别美国癌症联合委员会(AJCC)IB-III期黑色素瘤中的高危肿瘤。
Cancers (Basel). 2021 Jun 10;13(12):2902. doi: 10.3390/cancers13122902.
8
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma.黑色素瘤前哨淋巴结活检的再评估。
Curr Treat Options Oncol. 2021 Feb 9;22(3):22. doi: 10.1007/s11864-021-00819-2.
9
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.利用临床病理和基因表达模型识别 I/IIA 期黑色素瘤患者中疾病复发的高危人群。
Eur J Cancer. 2020 Nov;140:11-18. doi: 10.1016/j.ejca.2020.08.029. Epub 2020 Oct 5.
10
Cutaneous melanoma in Argentina: an analysis of its characteristics and regional differences.阿根廷的皮肤黑色素瘤:其特征及区域差异分析
Ecancermedicalscience. 2020 Mar 5;14:1017. doi: 10.3332/ecancer.2020.1017. eCollection 2020.